Guru Elementary Report for SWAV

Date:

Under is Validea’s guru elementary report for SHOCKWAVE MEDICAL INC (SWAV). Of the 22 guru methods we comply with, SWAV charges highest utilizing our Contrarian Investor mannequin primarily based on the printed technique of David Dreman. This contrarian technique finds essentially the most unpopular mid- and large-cap shares available in the market and appears for bettering fundamentals.

SHOCKWAVE MEDICAL INC (SWAV) is a large-cap progress inventory within the Medical Tools & Provides business. The ranking utilizing this technique is 64% primarily based on the agency’s underlying fundamentals and the inventory’s valuation. A rating of 80% or above sometimes signifies that the technique has some curiosity within the inventory and a rating above 90% sometimes signifies sturdy curiosity.

The next desk summarizes whether or not the inventory meets every of this technique’s exams. Not all standards within the beneath desk obtain equal weighting or are impartial, however the desk supplies a quick overview of the sturdy and weak factors of the safety within the context of the technique’s standards.

MARKET CAP: PASS
EARNINGS TREND: PASS
EPS GROWTH RATE IN THE IMMEDIATE PAST AND FUTURE: PASS
P/E RATIO: FAIL
PRICE/CASH FLOW (P/CF) RATIO: FAIL
PRICE/BOOK (P/B) VALUE: FAIL
PRICE/DIVIDEND (P/D) RATIO: FAIL
CURRENT RATIO: PASS
PAYOUT RATIO: PASS
RETURN ON EQUITY: PASS
PRE-TAX PROFIT MARGINS: PASS
YIELD: FAIL
LOOK AT THE TOTAL DEBT/EQUITY: FAIL

Detailed Evaluation of SHOCKWAVE MEDICAL INC

SWAV Guru Analysis

SWAV Fundamental Analysis

Extra Info on David Dreman

David Dreman Portfolio

About David Dreman: Dreman’s Kemper-Dreman Excessive Return Fund was one of many best-performing mutual funds ever, rating as the perfect of 255 funds in its peer teams from 1988 to 1998, in line with Lipper Analytical Companies. On the time Dreman printed Contrarian Funding Methods: The Subsequent Technology, the fund had been ranked primary in additional time intervals than any of the three,175 funds in Lipper’s database. Along with managing cash, Dreman can be a longtime Forbes journal columnist.

Further Analysis Hyperlinks

Top Healthcare Stocks

Dividend Aristocrats 2024

Wide Moat Stocks

Recession Proof Stocks

High Insider Ownership Stocks

Factor-Based Stock Portfolios

About Validea: Validea is aninvestment researchservice that follows the printed methods of funding legends. Validea gives each inventory evaluation and mannequin portfolios primarily based on gurus who’ve outperformed the market over the long-term, together with Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For extra details about Validea, click here

The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.

Share post:

Subscribe

Popular

More like this
Related